Pfizer Inc. will pay more than $60 million to settle charges brought against it by the Securities and Exchange Commission and the U.S. Department of Justice for violations of the Foreign Corrupt Practices Act (FCPA).
Pfizer Agrees to $60 Million in Settlements Amid Foreign Bribery Charges
